(Q38096994)

28 August 2017

title

Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases (English)

1 reference

28 August 2017

3

Björn Wängler

1 reference

28 August 2017

4

Carmen Wängler

1 reference

28 August 2017

2

Ralf Schirrmacher

1 reference

28 August 2017

Gabriel Fischer

1

1 reference

28 August 2017

publication date

5 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

883-890

1 reference

Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Multimeric alpha-MSH has increased efficacy to activate the melanocortin MC4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Novel DOTA-based prochelator for divalent peptide vectorization: synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Peptide heterodimers for molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Cell-specific targeting by heterobivalent ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Hitting multiple targets with multimeric ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Enhanced targeting with heterobivalent ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Peptide-targeted diagnostics and radiotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

18F-labeled BBN-RGD heterodimer for prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Iodine 125-labeled mesenchymal-epithelial transition factor binding peptide-click-cRGDyk heterodimer for glioma imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells: kinetics, dosimetry and effect on cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

Synthesis and receptor binding analysis of thirteen oligomeric alpha-MSH analogs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300081

7 January 2021

Identifiers

DOI

10.1002/CMDC.201300081

1 reference

28 August 2017

1 reference